Jul 2026· Biochemical and Biophysical Research Communications - BBRC· Vol 830, pp.
154293
· 0 citations· 23 references
Medicine
TL;DR
Findings suggest that UFC1 contributes to ACSL3 protein abundance, probably through UFMylation-associated suppression of proteasomal degradation, thereby supporting lipid homeostasis and proliferation in skeletal muscle myoblasts.
Abstract
Ordered proliferation of skeletal muscle myoblasts is essential for muscle development and repair and requires coordinated metabolic remodeling. Acyl-CoA synthetase long-chain family member 3 (ACSL3) activates long-chain fatty acids and thereby supports lipid metabolic flux, but the post-translational mechanisms regulating ACSL3 in myoblasts remain incompletely defined. UFMylation is a ubiquitin-like post-translational modification mediated by a cascade that includes the E2-conjugating enzyme UFC1. Here, we investigated whether UFC1 regulates ACSL3 abundance and lipid metabolism in C2C12 myoblasts and primary mouse skeletal muscle myoblasts. UFC1 knockout or knockdown reduced ACSL3 protein abundance, decreased myoblast proliferation, and lowered cellular neutral and polar lipid signals. Transcriptomic gene set enrichment analysis further indicated suppression of pathways related to unsaturated fatty acid biosynthesis and fatty acid metabolism after UFC1 loss. Co-immunoprecipitation showed an association between UFC1 and ACSL3, and endogenous immunoprecipitation detected a UFC1-dependent UFM1 signal on ACSL3. Cycloheximide chase assays indicated accelerated ACSL3 degradation in UFC1-deficient cells, whereas the proteasome inhibitor MG132 partially restored ACSL3 protein abundance. Overexpression of ACSL3 alleviated lipid metabolic defects and partially rescued proliferation in UFC1-deficient myoblasts. These findings suggest that UFC1 contributes to ACSL3 protein abundance, probably through UFMylation-associated suppression of proteasomal degradation, thereby supporting lipid homeostasis and proliferation in skeletal muscle myoblasts.
Integrative multi-omics analyses in EL4 T cells reveal unrecognized mechanisms of lipid metabolic adaptation and highlight a regulatory network that coordinates fatty acid uptake in response to impaired lipid synthesis.
Takeru Endo, T. Kanno, R. Konno et al.· Scientific Reports· 0 citations
This work integrates thermal proteome profiling with co-aggregation analysis to monitor protein thermal stability and complex assembly dynamics in response to two canonical inducers: Torin 1, which activates autophagy via mTOR inhibition, and CCCP, a mitochondrial uncoupler that triggers mitophagy.
Shuang Zhang, Ya Zeng, Feng-Ming Li et al.· Cell Communication and Signa...· 0 citations
Findings reveal an ACSL5-centered metabolic program that sustains pathogenic T-cell responses in SS and suggest ACSL5/FAO as a potential therapeutic target.
Xinyi Ren, Jun-Hao Yin, Xinyi Ma et al.· International Journal on Bio...· 0 citations
These findings identify TMEM135 as a central regulator of hepatic lipid metabolism and uncover a coordinated mechanism linking lipid availability, lipogenesis, and post-translational metabolic regulation.
Ryo Hagimori, Michael Landowski, Siyu Song et al.· bioRxiv· 0 citations
The findings suggest that targeting SLC25A46 represents a rational strategy to improve treatment outcomes in OC patients and highlight the critical role of SLC25A46/MARCHF5/CACT axis in facilitating cell proliferation and ferroptosis evasion in OC cells via activating fatty acid oxidation‐mediated ATP and NADPH product...
Yunge Gao, Jiatao Hao, Xiaohong Zhang et al.· Advancement of science· 0 citations
Findings establish the SLC25A1-regulated metabolic axis as a promising therapeutic target and offer a robust preclinical proof-of-concept for targeted gene therapies against liver fibrosis.
Shu-Qin Xue, Xiu-Juan Yin, Sicheng Shu et al.· Pharmacological Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.